<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Einstein (Sao Paulo)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Einstein (Sao Paulo)</journal-id>
      <journal-title-group>
        <journal-title>Einstein</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1679-4508</issn>
      <issn pub-type="epub">2317-6385</issn>
      <publisher>
        <publisher-name>Instituto de Ensino e Pesquisa Albert Einstein</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26061077</article-id>
      <article-id pub-id-type="pmc">4943823</article-id>
      <article-id pub-id-type="publisher-id">S1679-45082015RC2952</article-id>
      <article-id pub-id-type="doi">10.1590/S1679-45082015RC2952</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Aggressive angiomyxoma of the vulva: case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Ribeiro</surname>
            <given-names>Jos&#xE9; Carlos Castelo Branco</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
          <xref ref-type="author-notes" rid="fn1">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vieira</surname>
            <given-names>Sabas Carlos</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>da Silva</surname>
            <given-names>Benedito Borges</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>dos Santos</surname>
            <given-names>Lina Gomes</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Costa</surname>
            <given-names>Pedro V&#xED;tor Lopes</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>da Fons&#xEA;ca</surname>
            <given-names>Lia Andr&#xE9;a Costa</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label> Instituto de Doen&#xE7;as Tropicais Nathan Portella, Teresina, PI, Brazil.</aff>
      <aff id="aff2"><label>2</label>Universidade Federal do Piau&#xED;, Teresina, PI, Brazil.</aff>
      <author-notes>
        <corresp><label>Corresponding author</label>: Sabas Carlos Vieira &#x2013; Rua F&#xE9;lix Pacheco, 2159 room 305 &#x2013; Centro &#x2013; Zip code: 64001-160 &#x2013; Teresina, PI, Brazil &#x2013; Phone: (55 82) 3226-1555 &#x2013; E-mail: <email>sabas.vieira@uol.com.br</email></corresp>
        <fn fn-type="deceased" id="fn1">
          <label>&#x2020;</label>
          <p>in memorian</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Apr-Jun</season>
        <year>2015</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Apr-Jun</season>
        <year>2015</year>
      </pub-date>
      <volume>13</volume>
      <issue>2</issue>
      <fpage>276</fpage>
      <lpage>278</lpage>
      <history>
        <date date-type="received">
          <day>20</day>
          <month>8</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>12</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Female patient, 42-years-old, complaining of difficulty in urinating and swelling in the vulvar area for one year. Her gynecological examination showed extensive injury in the vulvar region and the biopsy done was inconclusive. The removal of the lesion was conducted. After the procedure, the patient remains free of recurrence for 15 months. This case highlights the need to consider angiomyxoma in the differential diagnosis for tumors of unknown cause in the vulvar region.</p>
      </abstract>
      <kwd-group>
        <kwd>Myxoma/diagnosis</kwd>
        <kwd>Vulvar neoplasms</kwd>
        <kwd>Case reports</kwd>
      </kwd-group>
      <counts>
        <fig-count count="6"/>
        <table-count count="0"/>
        <equation-count count="0"/>
        <ref-count count="7"/>
        <page-count count="3"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Aggressive angiomyxoma (AA) is a rare tumor with higher risk of infiltration and recurrence.<sup>(<xref rid="B1" ref-type="bibr">1</xref>)</sup> This tumor pathogenesis is unclear.<sup>(<xref rid="B2" ref-type="bibr">2</xref>)</sup> It occurs predominantly in vulvo-vaginal, perineal and groin region, and the diagnosis is made by histopathology examination. Treatment must be exeresis of the tumor such as GnRH agonists used with adjunct therapy.<sup>(<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B4" ref-type="bibr">4</xref>)</sup>
</p>
      <p>The AA was first described by Steeper and Rosai in 1983.<sup>(<xref rid="B4" ref-type="bibr">4</xref>)</sup> In 2009, less than 250 cases of angiomyxoma was described, which highlights the rarity of this disease.<sup>(<xref rid="B3" ref-type="bibr">3</xref>)</sup> Most of cases reported have been in women at reproductive age and those in fourth decade of life. The AA can affect women and men in a proportion of 6:1.<sup>(<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B5" ref-type="bibr">5</xref>)</sup>
</p>
      <p>We report a rare disease. From the best of our knowledge only 74 cases of AA were reported in the literature so far.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 42-year-old woman (G3P3(v)A0) sought the gynecology outpatient unit of the <italic>Hospital Get&#xFA;lio Vargas de Teresina </italic>in Piaui, Brazil, complaining of difficult to void and tumor in vulvar region for one year.</p>
      <p>Gynecological examination showed a large mass located in the groin and vulvar region that caused a decrease of vaginal cavity and bulging on its posterior wall (<xref rid="f01" ref-type="fig">Figure 1</xref>).</p>
      <p>
<fig id="f01" orientation="portrait" position="float"><label>Figure 1</label><caption><title>Pre-operative appearance. Large mass located in perineal and vulvar region</title></caption><graphic xlink:href="1679-4508-eins-13-2-0276-gf01"/></fig>
</p>
      <p>A biopsy of the lesion was done and showed proliferation of fibroblast and myofibroblast cells without atypia on abundant collagenous matrix with blood vessels in between. Absence of mitotic activity and/or necrosis.</p>
      <p>Computed tomography of groin region showed expansive pelvic lesion with hemorrhagic necrosis area in between, well-delimited, and with extension to vaginal route and presacral region, which determined bulging of circumscribed structures without signals of invasion to myoadipose plans.</p>
      <p>A complete exeresis of the lesion was conducted (30x20x10cm) located in vulvoperineal region that extended to posterior vaginal wall and to anterior wall of rectus (<xref rid="f02" ref-type="fig">Figure 2</xref>). The synthesis of the surgical defect was done with approximation of deep plans and suture of vulvoperineal region. A suction drain was used and it was removed on fifth day after the surgery. The patient was treated with metronidazol and ciprofloxacine for 14 days and evolved without any intercurrences.</p>
      <p>
<fig id="f02" orientation="portrait" position="float"><label>Figure 2</label><caption><title>Macroscopic appearance of tumors, which measured 18x11x13cm with undulating external surface and grayish-white, and lobulated cut surface, brilliant and grayish-white with myxoid areas</title></caption><graphic xlink:href="1679-4508-eins-13-2-0276-gf02"/></fig>
</p>
      <p>The histopathological exam of the specimen showed deep angiomyxoma (<xref rid="f03" ref-type="fig">Figure 3</xref>).</p>
      <p>
<fig id="f03" orientation="portrait" position="float"><label>Figure 3</label><caption><title>Microscopic appearance of the tumor. Vessels of medium size and thickened wall, involved by stromal cell layer of myxoid apperance. Hematoxylin and eosin 200X</title></caption><graphic xlink:href="1679-4508-eins-13-2-0276-gf03"/></fig>
</p>
      <p>Currently, the patient remains asymptomatic without evidence of disease for 15 months after the surgery.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>The AA is wrongly diagnosed in 80% of cases. Classic presentation is a mass of slowing growth, painless, located in vulva, perineum and buttock. Patients often report that the mass is asymptomatic.</p>
      <p>The pathogenesis of vulvar AA is poorly extended, however, genetic changes in short arm of the chromosome 12(12q) has been implicated as the cause.<sup>(<xref rid="B6" ref-type="bibr">6</xref>)</sup> The histopathology exam is the gold standard diagnosis and, often, shows vessels of medium size and thickness wall, rounded by layer of stromal cells of myxoid appearance.<sup>(<xref rid="B4" ref-type="bibr">4</xref>)</sup> Histologically this tumor is hypo-or moderately cellular being fusiform or stellar cells in between the myxoid matrix of mucopolysaccharides, involving a number of vessels of small and medium size &#x2013; being this latter, sometimes, of thickness and hyalinized wall.<sup>(<xref rid="B7" ref-type="bibr">7</xref>)</sup> In our case, the surgical specimen consisted of a tumor weighting 1,326g and measuring 18x11x13cm with undulating external surface, brilliant and grayish-white with myxoid areas. Under microscope middle size vessels were seen and a thickened wall, involved by stromal cells of myxoid appearance. Immunohistochemically, tumoral cells show immunoreactivity, at least focally, for specific vimentin and muscle-specific actin. The desmin-positivity is controversial. There are immunonegativity for carcino-embrio antigen, cytokeratin, VIII factor and S100 protein.<sup>(<xref rid="B7" ref-type="bibr">7</xref>)</sup>
</p>
      <p>Several modalities of imaging exams have been used to identify and describe AA. The ultrasonography usually reveals a cystic and hypoechoic mass. In general, computed tomography reveals a tumor with well-defined borders with low attenuation than muscles, probably due to loose myxoid stroma and high aqueous content of such tumor. In relation to muscles sings in magnetic resonance, the AA show a isointense signal in T1 and hyperintense in T2 weighted image.<sup>(<xref rid="B6" ref-type="bibr">6</xref>)</sup> Imaging studies are important in pre-operative evaluation since the tumor extension is frequently underestimated by physical examination. The early detection of recurrences can also be increased by inclusion of imaging studies in the follow-up protocol.<sup>(<xref rid="B1" ref-type="bibr">1</xref>)</sup>
</p>
      <p>Multiple modalities of treatment have been described, however, the complete surgical exeresis, when requested, must be considered. Partial exeresis can be justified when a high surgical morbidity is anticipated. Unfortunately, recurrences can occur, even with negative surgical margins. Several surgical or clinical approach can be used to treat this disease recurrence. The exeresis is still the best treatment, but gonadotropin-releasing hormone (GnRH) antagonist has been described to prevent recurrence in isolated cases.<sup>(<xref rid="B4" ref-type="bibr">4</xref>)</sup> Most of angiomyxomas show positivity to receptors of estrogen and progesterone, being probably hormone-dependent. For this reason, hormonal manipulation is believed to be a viable option for treatment. Analogs of GnRH have been used in some few cases of premenopausal women, but this tumor can regrowth once the therapy is discontinued. The pre-operative reduction of tumors using analogs of GnRH can increase the chances of complete excision and reduce the radicality of the surgical procedure.<sup>(<xref rid="B3" ref-type="bibr">3</xref>)</sup> Adjuvant hormonal treatment has been also described with tamoxifen and raloxifene with several degrees of success &#x2013; from no response to complete remission of primary or recurrence of AA. Radiotherapy and chemotherapy have been used as adjuvant therapies, but it is less likely that they are useful, because the AA has low mitotic activity. The arterial embolization has been also reported, but, generally, it is not conducted, once these tumors are fed by several vessels. Because of its rarity, the role of biopsy of sentinel lymph nodes and lymphadenectomy in AA is still unclear. Although the great availability of a number of treatment, the recurrence of AA is higher than 72%.<sup>(<xref rid="B6" ref-type="bibr">6</xref>)</sup>
</p>
      <p>No guidelines exist on the postoperative management of vulvar AA. However, because of high rate of recurrence and potential morbidity associated with non-diagnosed recurrences, several authors have recommend periodic evaluations with physical exam and magnetic resonance for up to 15 years after the treatment.<sup>(<xref rid="B6" ref-type="bibr">6</xref>)</sup>
</p>
      <p>Angiomyxoma must be always considered in differential diagnosis of mass in the vulva, perineum and buttocks. The histopathological exam is the best way to conduct the definitive diagnosis. Treatment must be exeresis of the tumor with agonists of GnRH with adjunct therapy.<sup>(<xref rid="B4" ref-type="bibr">4</xref>)</sup>
</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fetsch</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Laskin</surname>
              <given-names>WB</given-names>
            </name>
            <name>
              <surname>Lefkowitz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kindblom</surname>
              <given-names>LG</given-names>
            </name>
            <name>
              <surname>Meis-Kindblom</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Aggressive angiomyxoma: a clinicopathologic study of 29 female patients</article-title>
          <source>Cancer</source>
          <year>1996</year>
          <volume>78</volume>
          <issue>1</issue>
          <fpage>79</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="pmid">8646730</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nucci</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Weremowicz</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Neskey</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Sornberger</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tallini</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Morton</surname>
              <given-names>CC</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Chromosomal translocation t (8;12) induces aberrant HMGIC expression in aggressive angiomyxoma of the vulva</article-title>
          <source>Genes Chromosomes Cancer</source>
          <year>2001</year>
          <volume>32</volume>
          <issue>2</issue>
          <fpage>172</fpage>
          <lpage>176</lpage>
          <pub-id pub-id-type="pmid">11550285</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haldar</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Martinek</surname>
              <given-names>IE</given-names>
            </name>
            <name>
              <surname>Kehoe</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Aggressive angiomyxoma: a case series and literature review</article-title>
          <source>Eur J Surgical Oncol</source>
          <year>2010</year>
          <volume>36</volume>
          <issue>4</issue>
          <fpage>335</fpage>
          <lpage>339</lpage>
          <comment>Review</comment>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Faber</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Dunwoody</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kamal</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>A rarer case of a rare disease: aggressive angiomyxoma (AAM) in a sixteen year old</article-title>
          <source>West London Med J</source>
          <year>2013</year>
          <volume>5</volume>
          <issue>1</issue>
          <fpage>1</fpage>
          <lpage>5</lpage>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gonzaga</surname>
              <given-names>LF</given-names>
            </name>
            <name>
              <surname>Freitas</surname>
              <given-names>FC</given-names>
            </name>
            <name>
              <surname>Tavares</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Aggressive vaginal angiomyxoma mimicking urethral tumor</article-title>
          <source>Int Braz J Urol</source>
          <year>2005</year>
          <volume>31</volume>
          <issue>5</issue>
          <fpage>475</fpage>
          <lpage>476</lpage>
          <pub-id pub-id-type="pmid">16255796</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Elkattah</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sarkodie</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Otteno</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Fletcher</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Aggressive angiomyxoma of the vulva: a pr&#xE9;cis for primary care providers</article-title>
          <source>Case Rep Obstet Gynecol</source>
          <year>2013</year>
          <volume>2013</volume>
          <elocation-id/>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jardim</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Matos</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Falc&#xE3;o</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Dinis</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Angiomixoma agressivo da vulva</article-title>
          <source>Acta Med Port</source>
          <year>2001</year>
          <volume>14</volume>
          <issue>5-6</issue>
          <fpage>507</fpage>
          <lpage>510</lpage>
          <pub-id pub-id-type="pmid">11878162</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article id="TRpt" article-type="translation" xml:lang="pt">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Relato De Caso</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Angiomixoma agressivo da vulva: relato de caso</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Ribeiro</surname>
            <given-names>Jos&#xE9; Carlos Castelo Branco</given-names>
          </name>
          <xref ref-type="aff" rid="aff1002">
<sup>1</sup>
</xref>
          <xref ref-type="author-notes" rid="fn1002">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vieira</surname>
            <given-names>Sabas Carlos</given-names>
          </name>
          <xref ref-type="aff" rid="aff2002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Silva</surname>
            <given-names>Benedito Borges da</given-names>
          </name>
          <xref ref-type="aff" rid="aff2002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Santos</surname>
            <given-names>Lina Gomes dos</given-names>
          </name>
          <xref ref-type="aff" rid="aff2002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Costa</surname>
            <given-names>Pedro V&#xED;tor Lopes</given-names>
          </name>
          <xref ref-type="aff" rid="aff2002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fons&#xEA;ca</surname>
            <given-names>Lia Andr&#xE9;a Costa da</given-names>
          </name>
          <xref ref-type="aff" rid="aff2002">
<sup>2</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1002"><label>1</label>Instituto de Doen&#xE7;as Tropicais Nathan Portella, Teresina, PI, Brasil.</aff>
      <aff id="aff2002"><label>2</label>Universidade Federal do Piau&#xED;, Teresina, PI, Brasil.</aff>
      <author-notes>
        <corresp id="c01002"><label>Autor correspondente</label>: Sabas Carlos Vieira &#x2013; Rua F&#xE9;lix Pacheco, 2159 sala 305 &#x2013; Centro &#x2013; CEP: 64001-160 &#x2013; Teresina, PI, Brasil &#x2013; Tel.: (82) 3226-1555 &#x2013; E-mail: sabas.vieira@uol.com.br </corresp>
        <fn fn-type="deceased" id="fn1002">
          <label>&#x2020;</label>
          <p>in memorian</p>
        </fn>
      </author-notes>
      <abstract>
        <p>Paciente do g&#xEA;nero feminino, 42 anos, com queixas de dificuldade ao urinar e aumento de volume na regi&#xE3;o vulvar h&#xE1; 1 ano. Ao exame ginecol&#xF3;gico, apresentava extensa les&#xE3;o na regi&#xE3;o vulvar. Bi&#xF3;psia da les&#xE3;o foi inconclusiva. Realizou-se a ex&#xE9;rese da les&#xE3;o. A paciente permanece livre de recorr&#xEA;ncias h&#xE1; 15 meses. Este caso destaca a necessidade de considerar o angiomixoma no diagn&#xF3;stico diferencial de massas de causa desconhecida na regi&#xE3;o vulvar.</p>
      </abstract>
      <kwd-group>
        <kwd>Mixoma/diagn&#xF3;stico</kwd>
        <kwd>Neoplasias vulvares</kwd>
        <kwd>Relatos de casos</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <sec>
        <title>INTRODU&#xC7;&#xC3;O</title>
        <p>Angiomixoma agressivo (AA) &#xE9; um tumor raro, com elevado risco de infiltra&#xE7;&#xE3;o e recorr&#xEA;ncia local.<sup>(<xref rid="B1" ref-type="bibr">1</xref>)</sup> Sua patogenia n&#xE3;o &#xE9; clara.<sup>(<xref rid="B2" ref-type="bibr">2</xref>)</sup> Ocorre predominantemente em regi&#xE3;o vulvovaginal, perineal e p&#xE9;lvica, e o diagn&#xF3;stico &#xE9; dado por meio de exame histopatol&#xF3;gico. O tratamento deve ser a ex&#xE9;rese do tumor, com a op&#xE7;&#xE3;o de agonistas do GnRH usados com terapia adjunta.<sup>(<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B4" ref-type="bibr">4</xref>)</sup>
</p>
        <p>O AA foi primeiro descrito por Steeper e Rosai, em 1983.<sup>(<xref rid="B4" ref-type="bibr">4</xref>)</sup> Em 2009, existiam menos de 250 casos de angiomixoma descritos, o que destaca a raridade da doen&#xE7;a.<sup>(<xref rid="B3" ref-type="bibr">3</xref>)</sup> A maioria dos casos relatados tem sido em mulheres na idade reprodutiva na quarta d&#xE9;cada de vida. Os AA podem acometer mulheres e homens numa propor&#xE7;&#xE3;o de 6:1.<sup>(<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B5" ref-type="bibr">5</xref>)</sup>
</p>
        <p>Essa &#xE9; uma doen&#xE7;a rara e no melhor do nosso conhecimento existem apenas 74 casos de AA da vulva publicados na literatura.</p>
      </sec>
      <sec>
        <title>RELATO DO CASO</title>
        <p>Mulher, 42 anos (G3P3(v)A0) procurou o ambulat&#xF3;rio de ginecologia do Hospital Get&#xFA;lio Vargas de Teresina, no Piau&#xED;, com queixa de dificuldade ao urinar e tumora&#xE7;&#xE3;o na regi&#xE3;o vulvar h&#xE1; um ano.</p>
        <p>Ao exame ginecol&#xF3;gico constatou-se volumosa massa localizada na regi&#xE3;o perineal e vulvar, determinando diminui&#xE7;&#xE3;o da cavidade vaginal e abaulando sua parede posterior (<xref rid="f01002" ref-type="fig">Figura 1</xref>).</p>
        <p>
<fig id="f01002" orientation="portrait" position="float"><label>Figura 1</label><caption><title>Apar&#xEA;ncia pr&#xE9;-operat&#xF3;ria. Volumosa massa localizada na regi&#xE3;o perineal e vulvar</title></caption><graphic xlink:href="1679-4508-eins-13-2-0276-gf01-pt"/></fig>
</p>
        <p>Realizou-se bi&#xF3;psia da les&#xE3;o, que mostrou prolifera&#xE7;&#xE3;o de c&#xE9;lulas fibrobl&#xE1;sticas e miofibrobl&#xE1;sticas, sem atipias, em meio &#xE0; abundante matriz colagenizada com vasos sangu&#xED;neos de permeio. Aus&#xEA;ncia de atividade mit&#xF3;tica e/ou necrose.</p>
        <p>Tomografia computadorizada da pelve mostrou les&#xE3;o p&#xE9;lvica expansiva, com &#xE1;rea de necrose hemorr&#xE1;gica de permeio, bem delimitada, com extens&#xE3;o ao canal vaginal e regi&#xE3;o pressacral, determinando abaulamento das estruturas circunjacentes, sem sinais de invas&#xE3;o dos planos mioadiposos.</p>
        <p>Realizou-se a ex&#xE9;rese completa da les&#xE3;o (30x20x10cm) localizada na regi&#xE3;o vulvoperineal, que se estendia para a parede vaginal posterior e para parede anterior do reto (<xref rid="f02002" ref-type="fig">Figura 2</xref>). A s&#xED;ntese do defeito cir&#xFA;rgico foi realizada com aproxima&#xE7;&#xE3;o dos planos profundos e sutura da regi&#xE3;o vulvoperineal. Deixou-se um dreno de suc&#xE7;&#xE3;o, que foi retirado no quinto dia de p&#xF3;s-operat&#xF3;rio. A paciente fez uso de metronidazol e ciprofloxacino por 14 dias e evoluiu sem intercorr&#xEA;ncias.</p>
        <p>
<fig id="f02002" orientation="portrait" position="float"><label>Figura 2</label><caption><title>Apar&#xEA;ncia macrosc&#xF3;pica do tumor, cujas dimens&#xF5;es eram 18x11x13cm, com superf&#xED;cie externa ondulada e branco-acinzentada, e superf&#xED;cie de corte lobulada, brilhante e branco-acizentada com &#xE1;reas mixoides</title></caption><graphic xlink:href="1679-4508-eins-13-2-0276-gf02-pt"/></fig>
</p>
        <p>O histopatol&#xF3;gico da pe&#xE7;a constatou angiomixoma profundo (<xref rid="f03002" ref-type="fig">Figura 3</xref>).</p>
        <p>
<fig id="f03002" orientation="portrait" position="float"><label>Figura 3</label><caption><title>Apar&#xEA;ncia microsc&#xF3;pica do tumor. Vasos de tamanho m&#xE9;dio e parede espessada, circundados por uma camada de c&#xE9;lulas estromais de apar&#xEA;ncia mixoide. Hematoxilina e eosina 200X</title></caption><graphic xlink:href="1679-4508-eins-13-2-0276-gf03-pt"/></fig>
</p>
        <p>A paciente encontrava assintom&#xE1;tica e sem evid&#xEA;ncias de doen&#xE7;a em atividade 15 meses ap&#xF3;s a opera&#xE7;&#xE3;o.</p>
      </sec>
      <sec>
        <title>DISCUSS&#xC3;O</title>
        <p>A doen&#xE7;a &#xE9; diagnosticada erroneamente em 80% dos casos. A apresenta&#xE7;&#xE3;o cl&#xE1;ssica &#xE9; de uma massa de crescimento lento, indolor, localizada na regi&#xE3;o da vulva, per&#xED;neo ou gl&#xFA;teo. As pacientes frequentemente relatam que a massa &#xE9; assintom&#xE1;tica.</p>
        <p>A patog&#xEA;nese do AA vulvar &#xE9; pobremente entendida, entretanto altera&#xE7;&#xF5;es gen&#xE9;ticas no bra&#xE7;o curto do cromossomo 12 (12q) t&#xEA;m sido implicadas.<sup>(<xref rid="B6" ref-type="bibr">6</xref>)</sup> O histopatol&#xF3;gico &#xE9; o padr&#xE3;o-ouro para o diagn&#xF3;stico e, geralmente, mostra vasos de tamanho m&#xE9;dio e parede espessada, circundados por uma camada de c&#xE9;lulas estromais de apar&#xEA;ncia mixoide.<sup>(<xref rid="B4" ref-type="bibr">4</xref>)</sup> Histologicamente, esse tumor &#xE9; hipo ou moderadamente celular, estando as c&#xE9;lulas fusiformes ou estelares no meio de uma matriz mixoide de mucopolissacar&#xED;deos, englobando numerosos vasos de pequeno e m&#xE9;dio calibres &#x2212; estes &#xFA;ltimos, por vezes, de parede espessa e hialinizada.<sup>(<xref rid="B7" ref-type="bibr">7</xref>)</sup> No presente caso, a pe&#xE7;a cir&#xFA;rgica consistia de um tumor pesando 1.326g com dimens&#xF5;es de 18x11x13cm, com superf&#xED;cie externa ondulada e branco-acinzentada, e superf&#xED;cie de corte lobulada, brilhante e branco-acinzentada, com &#xE1;reas mixoides. Ao microsc&#xF3;pio, mostrava vasos de tamanho m&#xE9;dio e parede espessada, circundados por uma camada de c&#xE9;lulas estromais de apar&#xEA;ncia mixoide. Imunoistoquimicamente, as c&#xE9;lulas tumorais mostram imunorreatividade, pelo menos focalmente, para a vimentina e actina espec&#xED;fica de m&#xFA;sculo. A positividade para desmina &#xE9; controversa. H&#xE1; imunonegatividade para ant&#xED;geno carcinoembrion&#xE1;rio, citoqueratina, fator VIII e prote&#xED;na S100.<sup>(<xref rid="B7" ref-type="bibr">7</xref>)</sup>
</p>
        <p>Muitas modalidades de exames de imagem t&#xEA;m sido utilizadas na identifica&#xE7;&#xE3;o e na descri&#xE7;&#xE3;o de AA. A ultrassonografia usualmente revela uma massa c&#xED;stica ou hipoecoica. A tomografia computadorizada tipicamente revela um tumor com margens bem definidas, com atenua&#xE7;&#xE3;o menor que a de m&#xFA;sculos, provavelmente devido ao estroma mixoide frouxo e ao alto conte&#xFA;do aquoso desse tumor. Em rela&#xE7;&#xE3;o aos sinais musculares na resson&#xE2;ncia magn&#xE9;tica, AA mostra um sinal isointenso, nas imagens ponderadas em T1, e hiperintenso, nas imagens ponderadas em T2.<sup>(<xref rid="B6" ref-type="bibr">6</xref>)</sup> Estudos de imagem s&#xE3;o importantes na avalia&#xE7;&#xE3;o pr&#xE9;-operat&#xF3;ria, desde que a extens&#xE3;o do tumor &#xE9; frequentemente subestimada pelo exame f&#xED;sico. A detec&#xE7;&#xE3;o precoce de recorr&#xEA;ncias pode tamb&#xE9;m ser aumentada pela inclus&#xE3;o de estudos de imagem no protocolo de seguimento.<sup>(<xref rid="B1" ref-type="bibr">1</xref>)</sup>
</p>
        <p>M&#xFA;ltiplas modalidades de tratamento t&#xEA;m sido descritas, entretanto, a ex&#xE9;rese cir&#xFA;rgica completa &#x2013; quando poss&#xED;vel &#x2013; deve ser tentada. Ex&#xE9;rese parcial pode ser justificada quando uma alta morbidade operat&#xF3;ria &#xE9; antecipada. Infelizmente, recorr&#xEA;ncias podem ocorrer, mesmo com margens cir&#xFA;rgicas negativas. Muitas abordagens cir&#xFA;rgicas ou cl&#xED;nicas podem ser usadas para tratar a doen&#xE7;a recorrente. A ex&#xE9;rese &#xE9; ainda o melhor tratamento, mas agonistas do horm&#xF4;nio liberador da gonadotrofina (GnRH) t&#xEA;m sido descritos para prevenir a recorr&#xEA;ncia em casos isolados.<sup>(<xref rid="B4" ref-type="bibr">4</xref>)</sup> A maioria dos angiomixomas mostra positividade para os receptores de estrog&#xEA;nio e de progesterona, sendo provavelmente horm&#xF4;nio-dependentes. Assim, pensa-se que a manipula&#xE7;&#xE3;o hormonal &#xE9; uma op&#xE7;&#xE3;o vi&#xE1;vel de tratamento. An&#xE1;logos do GnRH t&#xEA;m sido usados em alguns poucos casos de mulheres na pr&#xE9;-menopausa, mas o tumor pode voltar a crescer, uma vez que a terapia &#xE9; descontinuada. O encolhimento pr&#xE9;-operat&#xF3;rio de tumores usando an&#xE1;logos do GnRH pode aumentar as chances de excis&#xE3;o completa e minimizar a radicalidade do procedimento cir&#xFA;rgico.<sup>(<xref rid="B3" ref-type="bibr">3</xref>)</sup> O tratamento hormonal adjuvante tamb&#xE9;m tem sido descrito com tamoxifeno e raloxifeno, com variados graus de sucesso &#x2212; indo de nenhuma resposta &#xE0; remiss&#xE3;o completa do AA prim&#xE1;rio ou recorrente. Radioterapia e quimioterapia t&#xEA;m sido usadas como terapias adjuvantes, mas &#xE9; pouco prov&#xE1;vel que sejam &#xFA;teis, visto que AA tem baixa atividade mit&#xF3;tica. A emboliza&#xE7;&#xE3;o arterial tem sido relatada, mas, geralmente, n&#xE3;o &#xE9; realizada, uma vez que esses tumores s&#xE3;o alimentados por muitos vasos. Devido &#xE0; sua raridade, o papel da bi&#xF3;psia do linfonodo sentinela e da linfadenectomia em AA est&#xE1; ainda por ser determinado. Apesar dessa ampla gama de tratamentos, a recorr&#xEA;ncia de AA &#xE9; reportada ser t&#xE3;o alta quanto 72%.<sup>(<xref rid="B6" ref-type="bibr">6</xref>)</sup>
</p>
        <p>N&#xE3;o existem <italic>guidelines</italic> sobre o manejo p&#xF3;s-operat&#xF3;rio do AA vulvar. No entanto, devido &#xE0; alta taxa de recorr&#xEA;ncia e &#xE0; potencial morbidade associada com recorr&#xEA;ncias n&#xE3;o diagnosticadas, muitos autores t&#xEA;m recomendado avalia&#xE7;&#xF5;es peri&#xF3;dicas, com exame f&#xED;sico e resson&#xE2;ncia magn&#xE9;tica, por at&#xE9; 15 anos ap&#xF3;s o tratamento.<sup>(<xref rid="B6" ref-type="bibr">6</xref>)</sup>
</p>
        <p>O angiomixoma deve sempre ser considerado no diagn&#xF3;stico diferencial de massas nas regi&#xF5;es vulvar, perineal e gl&#xFA;tea. O histopatol&#xF3;gico &#xE9; o &#xFA;nico modo de fazer o diagn&#xF3;stico definitivo. O tratamento deve ser a ex&#xE9;rese do tumor, com a op&#xE7;&#xE3;o de agonistas do GnRH usados com terapia adjunta.<sup>(<xref rid="B4" ref-type="bibr">4</xref>)</sup>
</p>
      </sec>
    </body>
  </sub-article>
</article>
</pmc-articleset>
